Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Common Equity (2016 - 2025)

Milestone Scientific (MLSS) has disclosed Common Equity for 16 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • Quarterly Common Equity fell 51.78% to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Dec 2025, down 51.78% year-over-year, with the annual reading at $2.8 million for FY2025, 51.78% down from the prior year.
  • Common Equity hit $2.8 million in Q4 2025 for Milestone Scientific, up from $2.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $19.0 million in Q1 2021 to a low of $2.5 million in Q3 2025.
  • Historically, Common Equity has averaged $9.6 million across 5 years, with a median of $8.0 million in 2023.
  • Biggest five-year swings in Common Equity: surged 3802.41% in 2021 and later crashed 64.7% in 2025.
  • Year by year, Common Equity stood at $16.2 million in 2021, then tumbled by 38.29% to $10.0 million in 2022, then fell by 19.93% to $8.0 million in 2023, then dropped by 27.21% to $5.8 million in 2024, then plummeted by 51.78% to $2.8 million in 2025.
  • Business Quant data shows Common Equity for MLSS at $2.8 million in Q4 2025, $2.5 million in Q3 2025, and $3.3 million in Q2 2025.